Woodley Farra Manion Portfolio Management Inc Amgen Inc Transaction History

Woodley Farra Manion Portfolio Management Inc

  • $2.1 Billion
  • Q2 2025

A detailed history of Woodley Farra Manion Portfolio Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Woodley Farra Manion Portfolio Management Inc holds 14,509 shares of AMGN stock, worth $4.27 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
14,509
Previous 14,406 0.71%
Holding current value
$4.27 Million
Previous $4.49 Million 9.74%
% of portfolio
0.19%
Previous 0.23%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025
BUY
$262.28 - $309.85 $27,014 - $31,914
103 Added 0.71%
14,509 $4.05 Million
Q1 2025

May 08, 2025
BUY
$258.59 - $327.36 $72,405 - $91,660
280 Added 1.98%
14,406 $4.49 Million
Q4 2024

Feb 06, 2025
BUY
$258.78 - $328.31 $96,007 - $121,803
371 Added 2.7%
14,126 $3.68 Million
Q3 2024

Nov 12, 2024
BUY
$309.38 - $337.38 $5,259 - $5,735
17 Added 0.12%
13,755 $4.43 Million
Q2 2024

Aug 13, 2024
SELL
$262.75 - $319.31 $5,780 - $7,024
-22 Reduced 0.16%
13,738 $4.29 Million
Q1 2024

May 10, 2024
SELL
$268.87 - $324.56 $297,639 - $359,287
-1,107 Reduced 7.45%
13,760 $3.91 Million
Q4 2023

Feb 13, 2024
SELL
$255.7 - $288.46 $141,913 - $160,095
-555 Reduced 3.6%
14,867 $4.28 Million
Q3 2023

Nov 13, 2023
SELL
$218.65 - $271.46 $163,987 - $203,594
-750 Reduced 4.64%
15,422 $4.14 Million
Q2 2023

Aug 14, 2023
SELL
$214.27 - $253.37 $114,848 - $135,806
-536 Reduced 3.21%
16,172 $3.59 Million
Q1 2023

May 10, 2023
SELL
$225.79 - $275.2 $98,444 - $119,987
-436 Reduced 2.54%
16,708 $4.04 Million
Q4 2022

Feb 13, 2023
SELL
$229.03 - $291.01 $477,069 - $606,173
-2,083 Reduced 10.83%
17,144 $4.5 Million
Q3 2022

Nov 14, 2022
SELL
$224.46 - $253.15 $77,887 - $87,843
-347 Reduced 1.77%
19,227 $4.33 Million
Q2 2022

Jul 22, 2022
BUY
$230.71 - $256.74 $35,067 - $39,024
152 Added 0.78%
19,574 $4.76 Million
Q1 2022

May 05, 2022
SELL
$219.27 - $242.57 $158,532 - $175,378
-723 Reduced 3.59%
19,422 $4.7 Million
Q4 2021

Feb 10, 2022
BUY
$198.88 - $227.6 $258,742 - $296,107
1,301 Added 6.9%
20,145 $4.53 Million
Q3 2021

Nov 12, 2021
SELL
$212.27 - $248.7 $213,755 - $250,440
-1,007 Reduced 5.07%
18,844 $4.01 Million
Q2 2021

Aug 10, 2021
BUY
$233.58 - $259.14 $65,869 - $73,077
282 Added 1.44%
19,851 $4.84 Million
Q1 2021

May 10, 2021
SELL
$221.91 - $258.6 $211,924 - $246,963
-955 Reduced 4.65%
19,569 $4.87 Million
Q4 2020

Feb 05, 2021
BUY
$216.38 - $257.67 $328,681 - $391,400
1,519 Added 7.99%
20,524 $4.72 Million
Q3 2020

Nov 05, 2020
SELL
$234.65 - $260.95 $719,436 - $800,072
-3,066 Reduced 13.89%
19,005 $4.83 Million
Q2 2020

Aug 12, 2020
SELL
$197.81 - $242.74 $50,243 - $61,655
-254 Reduced 1.14%
22,071 $5.21 Million
Q1 2020

May 08, 2020
SELL
$182.24 - $241.7 $97,133 - $128,826
-533 Reduced 2.33%
22,325 $4.53 Million
Q4 2019

Feb 14, 2020
SELL
$189.21 - $243.2 $38,977 - $50,099
-206 Reduced 0.89%
22,858 $5.51 Million
Q3 2019

Nov 13, 2019
BUY
$174.11 - $208.62 $78,697 - $94,296
452 Added 2.0%
23,064 $4.46 Million
Q2 2019

Aug 12, 2019
BUY
$166.7 - $195.41 $103,520 - $121,349
621 Added 2.82%
22,612 $4.17 Million
Q1 2019

May 14, 2019
BUY
$180.87 - $203.88 $3.79 Million - $4.27 Million
20,931 Added 1974.62%
21,991 $4.18 Million
Q4 2018

Feb 12, 2019
SELL
$178.4 - $208.25 $95,265 - $111,205
-534 Reduced 33.5%
1,060 $206,000
Q3 2018

Nov 13, 2018
BUY
$185.29 - $208.89 $46,322 - $52,222
250 Added 18.6%
1,594 $330,000
Q2 2017

Aug 11, 2017
BUY
N/A
1,344
1,344 $231,000

Others Institutions Holding AMGN

# of Institutions
3,275
Shares Held
442M
Call Options Held
6.15M
Put Options Held
7.25M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Woodley Farra Manion Portfolio Management Inc Portfolio

Follow Woodley Farra Manion Portfolio Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodley Farra Manion Portfolio Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Woodley Farra Manion Portfolio Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email